Barings’s Magellan Health Services, Inc. MGLN Stock Holding History

Barings’s Portfolio MGLN Stock Details MGLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-27,500	Closed	-$1.9M	–	956
2017 Q1	$1.9M	Buy	+27,500	New	+$2.01M	0.04%	368

Other funds holding MGLN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Barings's MGLN Position: Q2 2017 in Review

Barings sold out of Magellan Health Services, Inc. (MGLN) in Q2 2017, closing a stake of 27,500 shares — an estimated $1.9M sold.

Barings first reported a position in MGLN in Q1 2017 and held it in 1 quarter. The position peaked at $1.9M in Q1 2017. 194 funds tracked by Wall St. Rank hold MGLN as of Q2 2017.

Barings reported no remaining Magellan Health Services, Inc. position as of Q2 2017 after selling out during the quarter.
Barings sold 27,500 Magellan Health Services, Inc. shares in Q2 2017, an estimated $1.9M.
Barings first reported a position in Magellan Health Services, Inc. in Q1 2017 and held it in 1 quarter.
Barings's Magellan Health Services, Inc. position peaked at $1.9M in Q1 2017.
194 funds tracked by Wall St. Rank held Magellan Health Services, Inc. as of Q2 2017.

Based on Barings's 13F filing for Q2 2017, filed 14 Aug 2017.